Compare ALLE & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLE | GMED |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 12.9B |
| IPO Year | 2013 | 2012 |
| Metric | ALLE | GMED |
|---|---|---|
| Price | $136.41 | $91.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 14 |
| Target Price | ★ $167.13 | $100.42 |
| AVG Volume (30 Days) | ★ 933.3K | 903.9K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.60% | N/A |
| EPS Growth | 9.09 | ★ 422.67 |
| EPS | 1.59 | ★ 3.92 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | $8.47 | $11.13 |
| Revenue Next Year | $4.58 | $6.28 |
| P/E Ratio | $86.53 | ★ $23.04 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $134.67 | $51.79 |
| 52 Week High | $183.11 | $101.40 |
| Indicator | ALLE | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 35.53 | 50.62 |
| Support Level | N/A | $85.01 |
| Resistance Level | $167.42 | $93.85 |
| Average True Range (ATR) | 3.30 | 2.86 |
| MACD | -0.60 | -0.57 |
| Stochastic Oscillator | 3.98 | 41.92 |
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.